Interventional Solutions News Today

ADAGIO MEDICAL Investor Presentation | June 2024 1 DISCLAIMER This investor presentation is for informational purposes only to assist interested parties in making their...

Johnson & Johnson (NYSE:JNJ – Get Free Report) and Kyowa Kirin (OTCMKTS:KYKOF – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, valuation, earnings and institutional ownership. Profitability This table compares Johnson & Johnson […]

REFINITIV STREETEVENTS EDITED TRANSCRIPT Q1 2024 Johnson & Johnson Earnings Call EVENT...

Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in...

Operational Sales and Adjusted EPS See Notable Increases Amidst Strategic Focus

2023 Fourth-Quarter reported sales growth of 7.3% to $21.4 Billion with operational growth of 7.2%* and adjusted operational growth of 5.7%*. Operational growth excluding COVID-19 Vaccine of...

Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good morning, and welcome to Johnson & Johnson’s Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect […]

Media contact: Investor contact: ...

2023 Third-Quarter reported sales growth of 6.8% to $21.4 Billion with operational growth of 6.4%* and adjusted operational growth of 4.9%*. Operational growth excluding COVID-19 Vaccine of...

Company increases full-year guidance for sales and adjusted EPS